Norris Medicines Ltd. (NORRIS)
Market Open
15 Oct, 09:44 AM
MSE MSE Primary ₹
15. 33
-0.48
-3.0361%
₹
129.71M Market Cap
- P/E Ratio
- Div Yield
1,674 Volume
0 Eps
₹ 15.81
Previous Close Want to track NORRIS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Norris Medicines Ltd. (NORRIS) Statistics
Valuation metrics
Market Cap 129.71M
Enterprise value 152.51M
Trailing P/E (ttm) -41.22
Forward P/E -
PEG ratio -2.62
Price/Sales (ttm) 2.01
Price/Book (mrq) -1
Enterprise Value/Revenue 2.01
Enterprise Value/EBITDA 29.17
Overview
Shares outstanding 10M
Float 2.39M
Shares short -
% Held by insiders 0.76%
% Held by institutions -
Average volume (10 days) 390
Average volume (90 days) 1.02K
Price summary
52-Week low 12
52-Week high 20.06
Beta -0.88
50-Day moving average 16.25
200-Day moving average 14.99
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:10
Last split Date 22 Aug 2013
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -0.05%
Operating margin 0.24%
Operational effectiveness
Return on assets -0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) 94.44M
Revenue per share (ttm) 7.66
Quarterly revenue growth (yoy) 1.95%
Gross profit (ttm) 37.58M
EBITDA 4.74M
Net income to common (ttm) -5.6M
Diluted EPS (ttm) -0.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 646K
Total cash per share (mrq) 0.02
Total debt (mrq) 214.72M
Total Debt/Equity (mrq) -1.42
Current ratio (mrq) 0.61%
Book value per share (mrq) -15.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
